Acute & Chronic Inflammation There has been growing interest in GLP-1 microdosing for managing both acute and chronic inflammation, particularly in conditions such as PCOS, cardiovascular disease, and even sports performance
It is to find the dose that reduces inflammatory load while the deeper cellular work proceeds alongside it
From $550 8-week extended recovery-focused program
Although side effects to the injections are rare, and they are generally well tolerated, it is possible that some people can experience mild adverse effects
Curran MWT, Morhart MJ, Olson JL, et al
Many patients stay on a lower maintenance dose long-term as a chronic disease management tool, similar to medications for blood pressure or cholesterol